Abstract
We have examined the function of TIM-1, encoded by a gene identified as an 'atopy susceptibility gene' (Havcr1*), and demonstrate here that TIM-1 is a molecule that costimulates T cell activation. TIM-1 was expressed on CD4+ T cells after activation and its expression was sustained preferentially in T helper type 2 (TH2) but not TH1 cells. In vitro stimulation of CD4+ T cells with a TIM-1-specific monoclonal antibody and T cell receptor ligation enhanced T cell proliferation; in TH2 cells, such costimulation greatly enhanced synthesis of interleukin 4 but not interferon-γ. In vivo, the use of antibody to TIM-1 plus antigen substantially increased production of both interleukin 4 and interferon-γ in unpolarized T cells, prevented the development of respiratory tolerance, and increased pulmonary inflammation. Our studies suggest that immunotherapies that regulate TIM-1 function may downmodulate allergic inflammatory diseases.
NOTE: In the supplementary information initially published online to accompany this article, the legends for the supplementary figures are attached to the wrong figures. The error has been corrected online.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
30 March 2005
Changed a word in the abstract
27 November 2006
Corrected supp info files uploaded
Notes
NOTE:In the version originally published online, the gene symbol in the first sentence of the abstract was incorrect. The sentence should read as follows: “We have examined the function of TIM-1, encoded by a gene identified as an ‘atopy susceptibility gene’ (Havcr1), and demonstrate here that TIM-1 is a molecule that costimulates T cell activation.” This error has been corrected for the HTML version of this article online. The correction has been appended to the PDF version online.
References
Vetrie, D. et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361, 226–233 (1993).
Noguchi, M. et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147–157 (1993).
Schwarz, K. et al. RAG mutations in human B cell-negative SCID. Science 274, 97–99 (1996).
Macchi, P. et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377, 65–68 (1995).
Puel, A., Ziegler, S., Buckley, R. & Leonard, W. Defective IL7R expression in T−B+NK+ severe combined immunodeficiency. Nat. Genet. 20, 394–397 (1998).
McIntire, J.J. et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat. Immunol. 2, 1109–1116 (2001).
McIntire, J.J. et al. Immunology: hepatitis A virus link to atopic disease. Nature 425, 576 (2003).
Kuchroo, V.K., Umetsu, D.T., DeKruyff, R.H. & Freeman, G.J. The TIM gene family: emerging roles in immunity and disease. Nat. Rev. Immunol. 3, 454–462 (2003).
McIntire, J.J., Umetsu, D.T. & DeKruyff, R.H. TIM-1, a novel allergy and asthma susceptibility gene. Springer Semin. Immunopathol. 25, 335–348 (2004).
Feigelstock, D., Thompson, P., Mattoo, P., Zhang, Y. & Kaplan, G.G. The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J. Virol. 72, 6621–6628 (1998).
Matricardi, P.M. et al. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. Br. Med. J. 314, 999–1003 (1997).
Matricardi, P.M., Rosmini, F., Panetta, V., Ferrigno, L. & Bonini, S. Hay fever and asthma in relation to markers of infection in the United States. J. Allergy Clin. Immunol. 110, 381–387 (2002).
Ichimura, T. et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 273, 4135–4142 (1998).
Tsitoura, D.C., DeKruyff, R.H., Lamb, J.R. & Umetsu, D.T. Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. J. Immunol. 163, 2592–2600 (1999).
Tsitoura, D.C., Blumenthal, R.L., Berry, G., DeKruyff, R.H. & Umetsu, D.T. Mechanisms preventing allergen-induced airways hyperreactivity: Role of immune deviation and tolerance. J. Allergy Clin. Immunol. 106, 239–246 (2000).
Sharpe, A.H. & Freeman, G.J. The B7–CD28 superfamily. Nat. Rev. Immunol. 2, 116–126 (2002).
Croft, M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3, 609–620 (2003).
Sidorenko, S.P. & Clark, E.A. The dual-function CD150 receptor subfamily: the viral attraction. Nat. Immunol. 4, 19–24 (2003).
Monney, L. et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415, 536–541 (2002).
Sabatos, C.A. et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 4, 1102–1110 (2003).
Meyers, J. et al. Tim-4 is the ligand for Tim-1 and the Tim-1–Tim-4 interaction regulates T cell population expansion. Nat. Immunol. (in the press).
Sanchez-Fueyo, A. et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 4, 1093–1101 (2003).
Latchman, Y. et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2, 261–268 (2001).
Scheicher, C., Mehlig, M., Zecher, R. & Reske, K. Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. Methods 154, 253–264 (1992).
Inaba, K. et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693–1702 (1992).
Stockinger, B. & Hausmann, B. Functional recognition of in vivo processed self antigen. Int. Immunol. 6, 247–254 (1994).
Macaulay, A.E.H., D.R. & Umetsu, D.T. Antigen specific B cells preferentially induce CD4+ T cells to produce interleukin-4 by delivering a signal through the CD40 ligand. J. Immunol. 158, 4171–4179 (1997).
Acknowledgements
We thank G. Kaplan for discussions and B.-G. Zhu for technical assistance. Supported by the National Institutes of Health (PO1 AI54456 to D.T.U., R.D.K. and G.F.; and RO1 HL69507 to R.D.K.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Monoclonal antibody 3B3 is specific for mTIM-1. (PDF 181 kb)
Supplementary Fig. 2
Anti-mTIM-1 mAb 3B3 blocks binding of mTIM-1-Ig to 300.19 cells. (PDF 130 kb)
Supplementary Fig. 3
Monovalent Fab fragments of the anti-TIM-1 mAb bind to TIM-1. (PDF 151 kb)
Supplementary Fig. 4
Anti-Tim1 does not enhance IFN-γ production in TH1 cells at any dose of antigen. (PDF 149 kb)
Supplementary Fig. 5
TIM-1 expression on T cells from HBA mice. (PDF 314 kb)
Rights and permissions
About this article
Cite this article
Umetsu, S., Lee, WL., McIntire, J. et al. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 6, 447–454 (2005). https://doi.org/10.1038/ni1186
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1186
This article is cited by
-
TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway
BMC Cancer (2022)
-
Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease
Cellular & Molecular Immunology (2021)
-
Mapping and functional characterization of murine kidney injury molecule-1 proteolytic cleavage site
Molecular and Cellular Biochemistry (2021)
-
The expression of Tim-1 and Tim-4 molecules in regulatory T cells in type 1 diabetes
Endocrine (2020)
-
Inhibition of T cell immunoglobulin and mucin-1 (TIM-1) protects against cerebral ischemia-reperfusion injury
Cell Communication and Signaling (2019)